A global health organization is rolling out a new rapid serological assay for a mosquito-borne viral infection. In the initial validation study conducted in a highly endemic tropical country, the assay demonstrated a sensitivity of and a specificity of .
The organization is now deploying the identical assay to a temperate region where recent epidemiological surveys have established the disease prevalence to be .
Assuming the intrinsic properties of the assay remain unchanged, what is the expected positive predictive value of the assay in this temperate region?
- A
- B
- Answer
- D
- E
Answer
The expected positive predictive value in the temperate region is .
Positive Predictive Value (PPV) is the probability that a patient with a positive test result actually has the disease. It is calculated by dividing the number of true positives by the total number of positive results (true positives + false positives). In a hypothetical population of people with a disease prevalence, people have the disease and do not. A test with sensitivity correctly identifies of the diseased individuals (True Positives = ). A test with specificity correctly identifies of the healthy individuals, leaving individuals falsely identified as positive (False Positives = ). The total number of positive results is . Therefore, the PPV is , which equals or .
Step-by-Step Solution
Key Concept
The Positive Predictive Value (PPV) of a diagnostic test is heavily dependent on the prevalence of the disease in the tested population; to calculate it accurately, one must determine the absolute number of true positives and false positives in the specific population being tested.